Inari Medical Q3 2024 Adj EPS $(0.31) Misses $(0.11) Estimate, Sales $153.39M Beat $150.67M Estimate
Portfolio Pulse from Benzinga Newsdesk
Inari Medical reported Q3 2024 earnings with an adjusted EPS of $(0.31), missing the estimate of $(0.11). However, sales were $153.39M, beating the $150.67M estimate and showing a 21.39% increase from last year.
October 28, 2024 | 8:10 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Inari Medical's Q3 2024 earnings report showed a significant EPS miss but a sales beat, with a notable 21.39% year-over-year sales increase.
The significant EPS miss could negatively impact investor sentiment, but the sales beat and strong year-over-year growth may offset this. The mixed results suggest a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100